Ledger.Open graph →
SEC Form D · filed March 26, 2021

Vaxess Technologies, Inc

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Purnanand Sarma · Cambridge, MADirectorTed Hibben · Cambridge, MAExecMichael Schrader · Cambridge, MAExec · DirectorJonathan Kluge · Cambridge, MAExecAnn Dewitt · Cambridge, MADirectorLynda Tussey · Cambridge, MAExecKathryn Kosuda · Cambridge, MAExec · DirectorLivio Valenti · Cambridge, MAExecClea E. Kolster · Portland, ORDirectorWendy E. Holley · St. Helier, Y9Exec · DirectorKeith Manchester · Palo Alto, CAExec · DirectorMichael Blue · Seattle, WAExecNewton E. Mack · Portland, ORExecPeter E. Joseph · Portland, ORDirectorScott K. Bessent · Greenwich, CTExecJonathan G. Shulkin · Chicago, ILExecJohannes Fruehauf · New York, NYDirectorJulia Hu · Mountain View, CAExec · DirectorChristina Mcguire · London, United KingdomExecHelen Wetherall · St Helier, Y9ExecAnthony R. Sozio · New York, NYExec · DirectorJanine Aeroporos · Los Angeles, CAExecMark Ronay · PORTLAND, ORDirectorRonald J. Masciantonio · Philadelphia, PAExecLloyd T. Rochford · Rancho Mirage, CADirectorJohannes Fruehauf · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗